Page 108 - ASHG 2012 Annual Meeting Program Guide

INVITED AND PLATFORM SESSIONS
97
Taking photographs or sound recordings in all meeting rooms is strictly prohibited. Thank you for your cooperation.
INVITED AND PLATFORM SESSIONS
Thursday, November 8
4:30
PM
–6:45
PM
Concurrent Platform (abstract-driven)
Session C (38-46)
SESSION 42 – Cancer Genetics III: Common Variants
Gateway Ballroom 104, Lower Level South, Moscone
Center
Moderators
:
Kathleen Cooney, Univ. of Michigan;
Meredith Yeager, NCI/NIH
205
/4:30
Identification of 23 novel prostate cancer
susceptibility loci using a custom array (the iCOGS)
in an international consortium, PRACTICAL.
R.
Eeles, A. Amin Al Olama, S. Benlloch, E. Saunders, D.
Leongamornlert, M. Tymrakiewicz, M. Ghoussaini, C.
Luccarini, J. Dennis, S. Jugurnauth-Little, T. Dadaev,
PROTECT Group, G. Giles, G. Severi, F. Wiklund, H.
Gronberg, C. Haiman, F. Schumacher, B. Henderson,
L. Le Marchand, S. Lindstrom, P. Kraft, D. Hunter,
S. Gapstur, S. Chanock, S. Berndt, PRACTICAL
Consortium, Z. Kote-Jarai, D. Easton.
206
/4:45
Large-scale genotyping identifies more
than 40 novel breast cancer susceptibility loci.
K.
Michailidou, P. Hall, A. Gonzalez-Neira, M. Ghoussaini,
J. Dennis, R. L. Milne, M. K. Schmidt, J. Chang-
Claude, S. E. Bojesen, M. K. Humphreys, Q. Wang, M.
Garcia-Closas, P. D. P. Pharoah, G. Chenevix-Trench,
A. M. Dunning, J. Benitez, D. F. Easton, Breast Cancer
Association Consortium.
207
/5:00
Genome-wide association study in
BRCA1
mutation carriers identifies novel loci associated
with breast and ovarian cancer risk.
A. C. Antoniou,
X. Wang, L. McGuffog, A. Lee, M. M. Guedet, K. B.
Kuchenbaecker, P. Soucy, J. Simard, K. Offit, D. F.
Easton, G. Chenevix-Trench, F. J. Couch, Consortium
of Investigators of Modifiers of BRCA1/2.
208
/5:15
Identification of the first locus to modify
breast cancer risk specifically in
BRCA2
mutation
carriers.
K. Kuchenbaecker, M. Gaudet, J. Vijai,
R. Klein, T. Kirchhoff, L. McGuffog, D. Barrowdale,
A. Dunning, A. Lee, P. Hall, F. Couch, J. Simard, D.
Altshuler, D. Easton, G. Chenevix-Trench, A. Antoniou,
K. Offit, Consortium of Investigators of Modifiers of
BRCA1/2 (CIMBA) Collaborators.
209
/5:30
Fine-scale mapping and functional
analysis of the breast cancer 11q13 (
CCND1
)
locus.
M. Ghoussaini, K. B. Meyer, S. Edwards, J. D. French,
K. Michailidou, S. Ahmed, S. Khan, M. J. Maranian,
C. S. Healey, P. D. P. Pharoah, H. Nevanlinna,
M. A. Brown, G. Chenevix-Trench, D. F. Easton,
A. M. Dunning, BCAC.
210
/5:45
Three independent loci within the
TERT-
CLPTM1L
locus associated with telomere length
and risk of breast and ovarian cancer.
G. Chenevix-
Trench, S. E. Bojesen, K. A. Pooley, S. Johnatty,
J. Beesley, K. Michailidou, J. Tyrer, S. L. Edwards,
H. C. Shen, K. Lawrenson, H. Pickett, M. Stutz, C.
Smart, J. French, P. L. Mai, M. H. Greene, S. Gayther,
R. Reddel, P. D. P. Pharoah, E. L. Goode, A. Berchuk,
D. F. Easton, A. C. Antoniou, A. M. Dunning on behalf
of CIMBA, OCAC and BCAC.
211
/6:00
Statistical fine mapping of regions
containing melanoma susceptibility genes identified
through genome-wide association studies.
J. H.
Barrett, J. C. Taylor, M. Brossard, A. M. Goldstein,
P. A. Kanetsky, E. M. Gillanders, J. A. Newton Bishop,
D. T. Bishop, F. Demenais, M. M. Iles, GenoMEL
Consortium.
212
/6:15
Combining expression phenotypes with
high density imputation to identify melanoma risk
genes.
M. H. Law, G. W. Montgomery, K. M. Brown,
A. E. Cust, N. G. Martin, G. J. Mann, N. K. Hayward,
S. MacGregor, Q-MEGA and AMFS Investigators.
213
/6:30
Meta-analysis identifies four new loci for
testicular germ cell tumor.
C. C. Chung, Z. Wang,
P. A. Kanetsky, C. Turnbull, K. McGlynn, R. L. Erickson,
M. H. Greene, M. A. T. Hildebrandt, R. I. Skotheim,
C. Kratz, M. B. Cook, F. Schumacher, R. Koster,
M. Yeager, K. B. Jacobs, S. M. Schwartz, D. T. Bishop,
H. K. Gjessing, V. Cortessis, N. Rahman, X. Wu,
S. J. Chanock, K. L. Nathanson.